Jonathan Maelfait
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
- Virology top 5%
Papers in
- Immunology 29
- interferon and immune responses 24
- Immune Response and Inflammation 9
- Immune Cell Function and Interaction 3
-
- Inflammasome and immune disorders 7
- RNA regulation and disease 7
- Cell death mechanisms and regulation 6
- RNA Research and Splicing 4
- Co-authors
- Rudi Beyaert (9 shared papers)Jan Rehwinkel (11 shared papers)Anne Bridgeman (6 shared papers)Layal Liverpool (2 shared papers)Peter Vandenabeele (9 shared papers)Geert Loo (8 shared papers)Richard de Reuver (5 shared papers)Stefan Magez (1 shared paper)
- Journals
- PLoS Pathogens (4 papers)Cell Reports (3 papers)The Journal of Experimental Medicine (3 papers)The EMBO Journal (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- BelgiumUnited KingdomGermany
In The Last Decade
Jonathan Maelfait
30 papers receiving 2.2k citations
Jonathan Maelfait's Hit Papers
Peers
Comparison fields: 5 of 89
- Immunology 1.2k
- Virology 112
- Molecular Biology 1.3k
- Cancer Research 249
- Infectious Diseases 245
Countries citing papers authored by Jonathan Maelfait
This map shows the geographic impact of Jonathan Maelfait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Maelfait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Maelfait more than expected).
Fields of papers citing papers by Jonathan Maelfait
This network shows the impact of papers produced by Jonathan Maelfait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Maelfait. The network helps show where Jonathan Maelfait may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Maelfait, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 278 | |
| 2 | 2011 | 230 | |
| 3 | 2015 | 198 | |
| 4 | 2017 | 190 | |
| 5 | ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation Hit paper breakdown → | 2022 | 173 |
| 6 | 2013 | 125 | |
| 7 | 2020 | 94 | |
| 8 | 2008 | 93 | |
| 9 | 2016 | 86 | |
| 10 | 2012 | 80 | |
| 11 | 2021 | 80 | |
| 12 | 2012 | 69 | |
| 13 | 2015 | 64 | |
| 14 | 2019 | 61 | |
| 15 | 2021 | 58 | |
| 16 | 2022 | 54 | |
| 17 | 2023 | 52 | |
| 18 | 2016 | 47 | |
| 19 | 2020 | 43 | |
| 20 | 2010 | 37 |
About Jonathan Maelfait
Jonathan Maelfait is a scholar working on Immunology, Molecular Biology, Epidemiology, Cancer Research and Infectious Diseases, having authored 31 papers that have together received 2.2k indexed citations. Recurring topics across this work include interferon and immune responses (24 papers), Immune Response and Inflammation (9 papers), Inflammasome and immune disorders (7 papers), RNA regulation and disease (7 papers), Cell death mechanisms and regulation (6 papers), NF-κB Signaling Pathways (5 papers), RNA Research and Splicing (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (1.2k citations), Virology (112 citations), Molecular Biology (1.3k citations), Cancer Research (249 citations) and Infectious Diseases (245 citations). Jonathan Maelfait has collaborated with scholars based in Belgium, United Kingdom and Germany. Frequent co-authors include Rudi Beyaert, Jan Rehwinkel, Anne Bridgeman, Layal Liverpool, Peter Vandenabeele, Geert Loo, Richard de Reuver, Stefan Magez, Mira Haegman and Peter Schotte. Their work appears in journals such as PLoS Pathogens, Cell Reports, The Journal of Experimental Medicine, The EMBO Journal and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.